Fidelio-backed Vimian, has today been uplisted from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market – a significant milestone in the company’s growth journey.

Vimian is a global group of innovation-driven companies within animal health. Since its listing on First North in 2021, Vimian has continued to scale its platform, expanding into new markets and segments while maintaining a strong focus on innovation and long-term value creation.

The uplisting reflects Vimian’s continued growth, maturity, and ambition to become a global leader in its field.